Did Experimenter Bias Conceal the Efficacy of Spinal Opioids in Previous Studies with the Spinal Nerve Ligation Model of Neuropathic Pain?

Anesthesiology

Volumn 100, Issue 4, 2004, Pages 765-767

  Eisenach, James C ^a   Lindner, Mark D ^b  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MORPHINE; OPIATE DERIVATIVE;

ANALGESIC ACTIVITY; DRUG EFFICACY; EDITORIAL; EXPERIMENTATION; NERVE LIGATION; NEUROPATHIC PAIN; NONHUMAN; PAIN ASSESSMENT; PRIORITY JOURNAL; SPINAL NERVE; SYMPATHETIC TONE; TASK PERFORMANCE;

ANIMALS; BIAS (EPIDEMIOLOGY); DISEASE MODELS, ANIMAL; INJECTIONS, SPINAL; LIGATION; MORPHINE; PAIN; RATS; SPINAL NERVES;

EID: 1642416599     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200404000-00003     Document Type: Editorial

References (28)

1. Zhao C, Tall JM, Meyer RA, Raja SN: Antiallodynic effects of systemic and intrathecal morphine in the spared nerve injury model of neuropathic pain in rats. ANESTHESIOLOGY 2004; 100:905-11
2. Kim SH, Chung JM: An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 1992; 50:355-63
3. Coombs DW, Maurer LH, Saunders RL, Gaylor M: Outcomes and complications of continuous intraspinal narcotic analgesia for cancer pain control. J Clin Oncol 1984; 2:1414-20
4. Penn RD, Paice JA: Chronic intrathecal morphine for intractable pain. J Neurosurg 1987; 67:182-6
5. Arner S, Arner B: Differential effects of epidural morphine in the treatment of cancer-related pain. Acta Anaesthesiol Scand 1985; 29:32-6
6. Krames ES: Intraspinal opioid therapy for chronic nonmalignant pain: Current practice and clinical guidelines. J Pain Symptom Manage 1996; 11:333-52
7. Samuelsson H, Malmberg F, Eriksson M, Hedner T: Outcomes of epidural morphine treatment in cancer pain: Nine years of clinical experience. J Pain Symptom Manage 1995; 10:105-12
8. Winkelmuller M, Winkelmuller W: Long-term effects of continuous intrathecal opioid treatment in chronic pain of nonmalignant etiology. J Neurosurg 1996; 85:458-67
9. Hassenbusch SJ, Stanton-Hicks M, Covington EC, Walsh JG, Guthrey DS: Long-term intraspinal infusions of opioids in the treatment of neuropathic pain. J Pain Symptom Manage 1995; 10:527-43
10. Kim SH, Chung JM: Sympathectomy alleviates mechanical allodynia in an experimental animal model for neuropathy in the rat. Neurosci Lett 1991; 134:131-4
11. Bian D, Nichols ML, Ossipov MH, Lai J, Porreca F: Characterization of the antiallodynic efficacy of morphine in a model of neuropathic pain in rats. NeuroReport 1995; 6:1981-4
12. Lavand'homme PM, Eisenach JC: Exogenous and endogenous adenosine enhance the spinal antiallodynic effects of morphine in a rat model of neuropathic pain. Pain 1999; 80:31-6
13. Lee YW, Chaplan SR, Yaksh TL: Systemic and supraspinal, but not spinal, opioids suppress allodynia in a rat neuropathic pain model. Neurosci Lett 1995; 199:111-4
14. Xie J, Park SK, Chung K, Chung JM: The effect of lumbar sympathectomy in the spinal nerve ligation model of neuropathic pain. J Pain 2001; 2:270-8
15. Lavand'homme P, Pan HL, Eisenach JC: Intrathecal neostigmine, but not sympathectomy, relieves mechanical allodynia in a rat model of neuropathic pain. ANESTHESIOLOGY 1998; 89:493-9
16. Ringkamp M, Eschenfelder S, Grethel EJ, Habler HJ, Meyer RA, Janig W, Raja SN: Lumbar sympathectomy failed to reverse mechanical allodynia- and hyperalgesia-like behavior in rats with L5 spinal nerve injury. Pain 1999; 79:143-53
17. Shir Y, Ratner A, Raja SN, Campbell JN, Seltzer Z: Neuropathic pain following partial nerve injury in rats is suppressed by dietary soy. Neurosci Lett 1998; 240(2):73-6
18. Noseworthy JH, Ebers GC, Vandervoort MK, Farquhar RE, Yetisir E, Roberts R: The impact of blinding on the results of a randomized, placebo-controlled multiple sclerosis clinical trial. Neurology 1994; 44:16-20
19. Epstein WV: Expectation bias in rheumatoid arthritis clinical trials: The anti-CD4 monoclonal antibody experience. Arthritis Rheum 1996; 39:1773-80
20. Dworkin RH, Backonja M, Rowbotham MC, Allen RR, Argoff CR, Bennett GJ, Bushnell MC, Farrar JT, Galer BS, Haythornthwaite JA, Hewitt DJ, Loeser JD, Max MB, Saltarelli M, Schmader KE, Stein C, Thompson D, Turk DC, Wallace MS, Watkins LR, Weinstein SM: Advances in neuropathic pain: Diagnosis, mechanisms, and treatment recommendations. Arch Neurol 2003; 60:1524-34
21. Cordaro L, Ison JR: Psychology of the scientist: X. Observer bias in classical conditioning of the planarian. Psychol Rep 1963; 13:787-9
22. Rosenthal R, Fode KL: The effect of experimenter bias on the performance of the albino rat. Behav Sci 1963; 8:183-9
23. Rosenthal R, Lawson R: A longitudinal study of the effects of experimenter bias on the operant learning of laboratory rats. J Psychiatr Res 1963; 2:61-72
24. Berkson J, Magath TB, Hum M: The error of estimate of the blood cell count as made with the hemocytometer. Am J Physiol 1940; 128:309-23
25. Assmann SF, Pocock SJ, Enos LE, Kasten LE: Subgroup analysis and other (mis)uses of baseline data in clinical trials. Lancet 2000; 355:1064-9
26. Pocock SJ, Hughes MD, Lee RJ: Statistical problems in the reporting of clinical trials: A survey of three medical journals. N Engl J Med 1987; 317:426-32
27. Pocock SJ, Assmann SE, Enos LE, Kasten LE: Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: Current practice and problems. Stat Med 2002; 21:2917-30
28. Lindner MD, Frydel BR, Francis JM, Cain CK: Analgesic effects of adrenal chromaffin allografts: Contingent on special procedures or due to experimenter bias? J Pain 2003; 4:64-73